GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProQR Therapeutics NV (NAS:PRQR) » Definitions » 5-Year Yield-on-Cost %

ProQR Therapeutics NV (ProQR Therapeutics NV) 5-Year Yield-on-Cost % : 0.00 (As of May. 23, 2024)


View and export this data going back to 2014. Start your Free Trial

What is ProQR Therapeutics NV 5-Year Yield-on-Cost %?

ProQR Therapeutics NV's yield on cost for the quarter that ended in Mar. 2024 was 0.00.


The historical rank and industry rank for ProQR Therapeutics NV's 5-Year Yield-on-Cost % or its related term are showing as below:



PRQR's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.615
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of ProQR Therapeutics NV's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, ProQR Therapeutics NV's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProQR Therapeutics NV's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProQR Therapeutics NV's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where ProQR Therapeutics NV's 5-Year Yield-on-Cost % falls into.



ProQR Therapeutics NV 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of ProQR Therapeutics NV is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

ProQR Therapeutics NV  (NAS:PRQR) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


ProQR Therapeutics NV 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of ProQR Therapeutics NV's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


ProQR Therapeutics NV (ProQR Therapeutics NV) Business Description

Traded in Other Exchanges
Address
Zernikedreef 9, Leiden, ZH, NLD, 2333 CK
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.